Open Government Portal
Open Data Search has recently undergone significant changes. The search page has moved to search.open.canada.ca/opendata. Please update existing bookmarks accordingly.
Found 10 records similar to Cannabis for medical purposes under the Cannabis Act: information and improvements
Learn how to access cannabis for your medical purposes from licensed producers under the Access to Cannabis for Medical Purposes Regulations (ACMPR).
The Access to Cannabis for Medical Purposes Regulations (ACMPR) provide the legal means through which Canadians can obtain access to cannabis for medical purposes, except as noted below (see section regarding the injunction). Under section 15 of the ACMPR, any individual who possesses or produces fresh or dried marijuana, cannabis oil, marijuana plants or seeds (or a product derived from one of these substances) is required, at the request of a police officer, to demonstrate that they are authorized to do so.
Learn how to access or possess cannabis for your own medical purposes and register with Health Canada under the Cannabis Regulations.
Health Canada collects and publishes data on cannabis used for medical purposes under the Cannabis Act, the Cannabis Regulations, and the Cannabis Tracking System Order. Additional data on cannabis is available on the cannabis research and data page. In particular, the amount of cannabis sold for medical purposes is published on a quarterly basis and is available on the cannabis market data page.
How to access cannabis for medical purposes.
The Access to Cannabis for Medical Purposes Regulations provide a mechanism for patients to access cannabis for medical purposes with the support of their physician or nurse practitioner (where authorized by provincial regulatory authorities).
The Cannabis Act sets out a system for the legal, strictly regulated production, distribution and sale of cannabis
A federal licence is required to cultivate, process and sell cannabis for medical or non-medical purposes.
On August 24, 2016, Health Canada issued a Section 56 Class Exemption under the Controlled Drugs and Substances Act to enable registered persons under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and individuals responsible for them, to access testing services for dried or fresh marijuana or cannabis oil produced for their own medical purposes.
Pursuant to section 56 of the CDSA and subject to the terms and conditions set out herein, applicants for a producer’s licence are exempted from the requirement in paragraph 33(1)(h) to provide a detailed description of security measures determined in accordance with the Security Directive in respect of the storage of cannabis and from the application of paragraph 33(1)(h) of the ACMPR in respect of the proposed security measures that apply in respect of the areas where cannabis plants are cultivated, propagated, harvested or trimmed and to the areas where cannabis seeds are present or stored.